AR241632A1 - Procedimiento para preparar una composicion farmaceutica liquida de una 4-aroilimidazol-2-ona. - Google Patents

Procedimiento para preparar una composicion farmaceutica liquida de una 4-aroilimidazol-2-ona.

Info

Publication number
AR241632A1
AR241632A1 AR89313066A AR31306689A AR241632A1 AR 241632 A1 AR241632 A1 AR 241632A1 AR 89313066 A AR89313066 A AR 89313066A AR 31306689 A AR31306689 A AR 31306689A AR 241632 A1 AR241632 A1 AR 241632A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
aroylimidazol
ones
composition
unmarkled
Prior art date
Application number
AR89313066A
Other languages
English (en)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of AR241632A1 publication Critical patent/AR241632A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR UNA COMPOSICION FARMACEUTICA LIQUIDA, QUE COMPRENDE MEZCLAR A) UNA CANTIDAD EFICAZ DE UNA 4-AROILIMIDAZOL-2-ONA, O UNA SAL FARMACEUTICAMENTE ACEPTABLES DE LA MISMA Y B) UNO O MAS TENSOACTIVOS NO IONICOS FARMACEUTICAMENTE ACEPTABLES UN UNA CANTIDAD DE 30% AL 99% EN PESO DE LA COMPOSICION, Y OPCIONALMENTE MEZCLAR ADEMAS UNO O MAS EXCIPIENTES FARMACEUTICAMENTE ACEPTABLES DISTINTOS DE LOS TENSOACTIVOS NO IONICOS EN UNA CANTIDAD TOTAL DE HASTA 45% EN PESO DE LA COMPOSICION, TALES EXCIPIENTES SUPONIENDO SIEMPRE LA AUSENCIA DE AGUA.
AR89313066A 1988-01-29 1989-01-25 Procedimiento para preparar una composicion farmaceutica liquida de una 4-aroilimidazol-2-ona. AR241632A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14980388A 1988-01-29 1988-01-29

Publications (1)

Publication Number Publication Date
AR241632A1 true AR241632A1 (es) 1992-10-30

Family

ID=22531858

Family Applications (1)

Application Number Title Priority Date Filing Date
AR89313066A AR241632A1 (es) 1988-01-29 1989-01-25 Procedimiento para preparar una composicion farmaceutica liquida de una 4-aroilimidazol-2-ona.

Country Status (17)

Country Link
EP (1) EP0326103B1 (es)
JP (1) JPH01226817A (es)
KR (1) KR890011594A (es)
CN (1) CN1035242A (es)
AR (1) AR241632A1 (es)
AT (1) ATE78161T1 (es)
AU (1) AU611757B2 (es)
DE (1) DE68902056T2 (es)
DK (1) DK169566B1 (es)
ES (1) ES2051898T3 (es)
GR (1) GR3005792T3 (es)
HU (1) HUT49282A (es)
IE (1) IE62426B1 (es)
IL (1) IL89049A0 (es)
NZ (1) NZ227700A (es)
PT (1) PT89561B (es)
ZA (1) ZA89552B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2038744C (en) * 1990-03-23 2002-01-08 Yoshitomi Pharmaceutical Industries Ltd. Pharmaceutical composition containing slightly water-soluble drug
US20060018970A1 (en) * 2003-12-12 2006-01-26 Myogen, Inc. Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
CA2572179A1 (en) * 2004-06-23 2006-01-19 Myogen, Inc. Enoximone formulations and their use in the treatment of pde-iii mediated diseases
EP2581082B1 (de) 2011-10-10 2015-12-30 Carinopharm GmbH Pharmazeutische Zusammensetzung zur Behandlung von Status asthmaticus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405635A (en) * 1979-06-18 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Aroylimidazol-2-ones and their use as pharmaceuticals
EP0031603A1 (en) * 1979-12-31 1981-07-08 American Cyanamid Company Pharmaceutical composition of matter
OA06863A (fr) * 1980-08-04 1983-02-28 Merck & Co Inc Solubilisation de l'invermectine dans l'eau.
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs

Also Published As

Publication number Publication date
IE62426B1 (en) 1995-02-08
EP0326103B1 (en) 1992-07-15
JPH01226817A (ja) 1989-09-11
DE68902056T2 (de) 1992-12-03
DK37589A (da) 1989-07-30
IL89049A0 (en) 1989-08-15
PT89561A (pt) 1989-10-04
DK169566B1 (da) 1994-12-05
CN1035242A (zh) 1989-09-06
ES2051898T3 (es) 1994-07-01
DK37589D0 (da) 1989-01-27
ZA89552B (en) 1989-10-25
EP0326103A1 (en) 1989-08-02
NZ227700A (en) 1990-09-26
AU2876889A (en) 1989-08-03
DE68902056D1 (de) 1992-08-20
KR890011594A (ko) 1989-08-21
AU611757B2 (en) 1991-06-20
PT89561B (pt) 1994-01-31
HUT49282A (en) 1989-09-28
IE890275L (en) 1989-07-29
ATE78161T1 (de) 1992-08-15
GR3005792T3 (es) 1993-06-07

Similar Documents

Publication Publication Date Title
IT1247529B (it) Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale
IT8719064A0 (it) Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive.
MX9200180A (es) DERIVADOS DE LA 5H-PIRROL (3,4-b) PIRAZINA OPTICAMENTE ACTIVOS, PROCEDIMIENTO PARA SU PREPARACION Y COMPOSICION FARMACEUTICA QUE LOS CONTIENE.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
SE8700499L (sv) Nya farmakologiskt aktiva foreningar
MX9204354A (es) Compuestos heterociclicos de 5 miembros, procedimiento para prepararlos y composiciones farmaceuticas que los contienen.
MX9204140A (es) Nuevos derivados de analogos de taxol, procedimiento para su preparacion y composicion farmaceutica que los contienen.
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
ES2051678T1 (es) Derivados de 5-oxo-l-prolina y uso farmaceutico de los mismos.
KR880701244A (ko) 위치 17에 스피로 고리가 있는 스테로이드, 이들의 제조 방법 및 중간체 약제로서 이들의 사용, 및 이들을 함유하는 약제학적 조성물
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ITMI931326A1 (it) Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
IT8047848A0 (it) Derivati triciclici e loro sali farmacologicamente attivi e composizioni farmaceutiche che li contengono, nonche' procedimento per la loro preparazione
ES2020171T3 (es) Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos.
ES2174054T3 (es) Composiciones farmaceuticas acuosas liquidas que comprenden alginato sodico y bicarbonato potasico.
IT1272149B (it) Composizione farmeceutiche ad attivita' analgesica
ES2099021B1 (es) Composicion farmaceutica que tiene actividad analgesica.
BR9915215A (pt) Composição farmacêutica para liberação modificada de sensibilizador de insulina
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
DK494684A (da) Benzensulfonyl-lactamer, fremgangsmaade til deres fremstilling og deres anvendelse som aktiv komponent i framaceutiske kompositioner
AR241632A1 (es) Procedimiento para preparar una composicion farmaceutica liquida de una 4-aroilimidazol-2-ona.
DK498384D0 (da) N-cycliske benzensulfonamider, fremgangsmaade til deres fremstilling og deres anvendelse som aktiv komponent i farmaceutiske kompositioner
NO881778D0 (no) Inkastiner: nye glykopeptider med enkefalinase-hemmende virkning. fremgangsmaate til deres fremstilling og deres anvendelse som farmasoeytiske preparater.
GB2021409A (en) Pharmaceutical composition
EP0351876A3 (en) Composition for potentiating vaccination effect